Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 088786108 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Armistice Capital, LLC
13G/A
Amendment 2
|
6.7% |
8/14/2026
Event 6/30/2026
|
|
| Armistice Capital, LLC | 6.7% | ||
| Steven Boyd | 6.7% | ||
|
Armistice Capital, LLC
13G/A
Amendment 1
|
6.8% |
5/15/2026
Event 3/31/2026
|
|
| Armistice Capital, LLC | 6.8% | ||
| Steven Boyd | 6.8% | ||
|
Long Focus Capital Management, LLC
13G
|
6.6% |
5/15/2026
Event 3/31/2026
|
|
| Long Focus Capital Management, LLC | 6.6% | ||
| John Helmers | 6.6% | ||
|
Invus Global Management, LLC
13G/A
Amendment 1
|
3.1% |
5/4/2026
Event 3/31/2026
|
|
| Invus Public Equities, L.P. | 2.7% | ||
| Invus Public Equities Advisors, LLC | 2.7% | ||
| Invus Global Management, LLC | 2.7% | ||
| Siren, L.L.C. | 2.7% | ||
| Avicenna Life Sci Master Fund LP | 0.4% | ||
| Avicenna Life Sci Master GP LLC | 0.4% | ||
| Ulys, L.L.C. | 0.4% | ||
| Raymond Debbane | 3.1% | ||
| Westfield Capital Management Co LP 13G/A Amendment 3 | 0% |
3/4/2026
Event 2/28/2026
|
|
|
Invus Global Management, LLC
13G
|
6.3% |
3/3/2026
Event 2/25/2026
|
|
| Invus Public Equities, L.P. | 5.4% | ||
| Invus Public Equities Advisors, LLC | 5.4% | ||
| Invus Global Management, LLC | 5.4% | ||
| Siren, L.L.C. | 5.4% | ||
| Avicenna Life Sci Master Fund LP | 0.9% | ||
| Avicenna Life Sci Master GP LLC | 0.9% | ||
| Ulys, L.L.C. | 0.9% | ||
| Raymond Debbane | 6.3% | ||
| Westfield Capital Management Co LP 13G/A Amendment 2 | 0% |
3/3/2026
Event 12/31/2025
|
|
| Westfield Capital Management Co LP 13G/A Amendment 2 | 0% |
3/3/2026
Event 12/31/2025
|
|
|
Armistice Capital, LLC
13G
|
6.5% |
2/18/2026
Event 12/31/2025
|
|
| Armistice Capital, LLC | 6.5% | ||
| Steven Boyd | 6.5% | ||
| Westfield Capital Management Co LP 13G/A Amendment 1 | 6.0% |
2/11/2026
Event 12/31/2025
|
|
|
Armistice Capital, LLC
13G/A
Amendment 2
|
10.0% |
8/14/2025
Event 6/30/2025
|
|
| Armistice Capital, LLC | 10.0% | ||
| Steven Boyd | 10.0% | ||
|
Deep Track Capital, LP
13G/A
Amendment 5
|
2.4% |
8/14/2025
Event 6/30/2025
|
|
| Deep Track Capital, LP | 2.4% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 2.4% | ||
| David Kroin | 2.4% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 2
|
3.9% |
8/14/2025
Event 6/30/2025
|
|
| Point72 Asset Management, L.P. | 3.9% | ||
| Point72 Capital Advisors, Inc. | 3.9% | ||
| Steven A. Cohen | 3.9% | ||
|
Armistice Capital, LLC
13G
|
5.6% |
5/15/2025
Event 3/31/2025
|
|
| Armistice Capital, LLC | 5.6% | ||
| Steven Boyd | 5.6% | ||
|
Deep Track Capital, LP
13G/A
Amendment 4
|
5.7% |
5/15/2025
Event 3/31/2025
|
|
| Deep Track Capital, LP | 5.7% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 5.7% | ||
| David Kroin | 5.7% | ||
|
Point72 Asset Management, L.P.
13G/A
Amendment 1
|
7.8% |
5/15/2025
Event 3/31/2025
|
|
| Point72 Asset Management, L.P. | 7.8% | ||
| Point72 Capital Advisors, Inc. | 7.8% | ||
| Steven A. Cohen | 7.8% | ||
|
Deep Track Capital, LP
13G/A
Amendment 3
|
6.7% |
2/14/2025
Event 12/31/2024
|
|
| Deep Track Capital, LP | 6.7% | ||
| Deep Track Biotechnology Master Fund, Ltd. | 6.7% | ||
| David Kroin | 6.7% | ||
| Westfield Capital Management Co LP 13G | 5.5% |
2/11/2025
Event 12/31/2024
|
|
|
Point72 Asset Management, L.P.
13G
|
8.9% |
12/20/2024
Event 12/13/2024
|
|
| Point72 Asset Management, L.P. | 8.9% | ||
| Point72 Capital Advisors, Inc. | 8.9% | ||
| Steven A. Cohen | 8.9% | ||
|
Forbion Growth Opportunities Fund II Cooperatief U.A.
13G
|
7.3% |
12/19/2024
Event 11/21/2024
|
|
| Forbion Growth Opportunities Fund II Cooperatief U.A. | 7.3% | ||
| Forbion Growth II Management B.V. | 7.3% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 7.56 k | $27.8 k |
| 2026 Q2 | 112 | 37.5 M | $159 M |
| 2026 Q1 | 103 | 37.5 M | $174 M |
| 2025 Q4 | 116 | 39.2 M | $278 M |
| 2025 Q3 | 104 | 36.9 M | $286 M |
| 2025 Q2 | 119 | 41.2 M | $286 M |
| 2025 Q1 | 98 | 41.7 M | $354 M |
| 2024 Q4 | 101 | 41.9 M | $585 M |
| 2024 Q3 | 112 | 40.4 M | $911 M |
| 2024 Q2 | 114 | 41.5 M | $839 M |
| 2024 Q1 | 103 | 33.5 M | $835 M |
| 2023 Q4 | 113 | 33.0 M | $596 M |
| 2023 Q3 | 107 | 32.4 M | $651 M |
| 2023 Q2 | 93 | 24.3 M | $619 M |
| 2023 Q1 | 99 | 23.6 M | $499 M |
| 2022 Q4 | 95 | 23.6 M | $698 M |
| 2022 Q3 | 84 | 25.6 M | $596 M |
| 2022 Q2 | 88 | 23.2 M | $389 M |
| 2022 Q1 | 120 | 20.3 M | $892 M |
| 2021 Q4 | 111 | 21.6 M | $1.31 B |
| 2021 Q3 | 77 | 14.2 M | $591 M |
| 2021 Q2 | 58 | 12.6 M | $383 M |
| 2021 Q1 | 41 | 11.4 M | $341 M |
| 2020 Q4 | 28 | 7.33 M | $132 M |
| 2020 Q3 | 19 | 7.55 M | $144 M |
| 2020 Q2 | 17 | 6.29 M | $98.9 M |
| 2020 Q1 | 16 | 6.20 M | $85.1 M |
| 2019 Q4 | 11 | 5.90 M | $55.7 M |
| 2019 Q3 | 12 | 6.45 M | $73.4 M |
| 2019 Q2 | 16 | 6.64 M | $66.8 M |